Trial AGO-OVAR 2.15 / AURELIA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

AGO-OVAR 2.15 / AURELIA

Full title

Eine multizentrische, offene, randomisierte, zweiarmige Phase III Studie mit Bevacizumab plus Chemotherapie versus Chemotherapie als Monotherapie bei Patientinnen mit platin-resistentem epithelialen Ovarial-, Tuben- oder primären Peritonealkarzinom

EudraCT number

2009-011400-33

NCT number

NCT00976911

Responsible organization

Frauenklinik GH, Telefon: 089440076800

Indications

Classification	Code	Description
-		Gynecological tumor

Trial design

Trial type

Interventional

Blinding type

Open

Phase

III

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2014-07-31 / Unknown

Participants

	Function	Prename	Surname	Organization
	Principal Investigator	Alexander	Burges	Keine Organisationseinheit angegeben